DEADLINE ALERT for ARE, SFM, DEFT, OWL: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions GlobeNewswire January 26, 2026 BENSALEM, Pa., Jan. 26, 2026 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of […]
Many homeowners in Lighthouse Point, Florida, are choosing home window tinting for the wide range of benefits it provides. The best part is that tinting is not a one-size-fits-all solution – there are numerous styles, shades, and features to choose from. No matter the goals or preferences, there’s a window film option to fit every
At a time when many lenders rely on automated systems and faceless algorithms to approve or deny applications, FundKite is taking a different path – one that many entrepreneurs say is long overdue. By combining technology with human judgment, FundKite is redefining what the best business funding looks like for small and growing companies across
Three first-to-market single-stock leveraged ETFs seeking 200% long exposure Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announced that it expects to launch three new single stock leveraged ETFs on Tuesday, January 27. The funds will be listed on Cboe and all three represent first-to-market strategies. Each ETF aims to
(NasdaqGM:BBNX), ATLANTA, Jan. 26, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) complied with federal securities laws. On January 8, 2026, Beta Bionics announced preliminary, unaudited fourth quarter 2025 topline financial results, reporting that new patient starts, or the total number of
INVESTOR ALERT: Investigation of Beta Bionics, Inc. (BBNX) by Holzer & Holzer, LLC GlobeNewswire January 26, 2026 ATLANTA, Jan. 26, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) complied with federal securities laws. On January 8, 2026, Beta Bionics announced preliminary, unaudited
Lehi, Utah, Jan. 26, 2026 (GLOBE NEWSWIRE) — DigiCert, a global leader in intelligent trust, today announced that the company has been named a Leader in the IDC MarketScape: Worldwide Certificate Lifecycle Management (CLM) Vendor Assessment (doc #US52990725, January 2026). The recognition highlights DigiCert's leadership in helping organizations modernize PKI and automate certificate lifecycle operations
DigiCert Named a Leader in IDC MarketScape for Worldwide Certificate Lifecycle Management 2026 GlobeNewswire January 26, 2026 Lehi, Utah, Jan. 26, 2026 (GLOBE NEWSWIRE) — DigiCert, a global leader in intelligent trust, today announced that the company has been named a Leader in the IDC MarketScape: Worldwide Certificate Lifecycle Management (CLM) Vendor Assessment (doc #US52990725,
(NASDAQ:MREO), ATLANTA, Jan. 26, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO) complied with federal securities laws. On December 29, 2025, Mereo announced the results from its Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta, revealing that, “[n]either
INVESTOR ALERT: Investigation of Mereo BioPharma Group plc (MREO) by Holzer & Holzer, LLC GlobeNewswire January 26, 2026 ATLANTA, Jan. 26, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO) complied with federal securities laws. On December 29, 2025, Mereo announced the results